Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference

SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the JPMorgan Healthcare Conference inSan Francisco on Monday, January 12, 2009 at 10:00 a.m. PT / 1:00 p.m. ET. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation and breakout session will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate

Web site, located at www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered inSan Diego, California. Further information about Amylin Pharmaceuticals is available at www.amylin.com.

SOURCE Amylin Pharmaceuticals, Inc.

Tags: ,HEA,MTC,CCA,TDS,CA-AMLN-Health-Confer

Editorial Cartoons
Political Cartoons

<style> /* RESET STYLES */ .fxw hr,.fxw div,.fxw span,.fxw h1,.fxw h2,.fxw h3,.fxw p,.fxw a,.fxw em,.fxw img,.fxw strong,.fxw ol,.fxw ul,.fxw li {margin: 0;padding: 0;border: 0;outline: 0;font-weight: inherit;font-style: inherit;font-size: 100%;font-family: inherit;vertical-align: baseline;line-height: 1;list-style: none; } .fxw {font-family: Arial, sans-serif !important;font-size: 11px !important;border: 1px solid #004c00;background-color: #fff;position: relative !important;} .fxw .clear {clear: both !important;height: 1px !important;overflow: hidden !important; } /* Header */ .fxw_header {color: #fff;background: #004c00;padding: 10px !important;font-weight: bold !important;font-size: 14px !important;} /* Footer */ .fxw_footer {color: #fff;background: #004c00;padding: 10px !important;} .fxw_footer a{text-decoration: none !important;font-weight: bold !important;color: #fff;} .fxw_footer .fxw_pipe {padding: 0px 3px 0px 3px;} /* Body */ .fxw_body {padding: 10px !important;overflow: auto !important; } /* Story Item */ .fxw_story {border-bottom: 1px solid #e3e3e3 !important;padding-bottom: 8px !important;margin-bottom: 8px !important;} .fxw_story.fxw_last {border: 0px !important;} .fxw_story.fxw_image {padding-left: 60px !important;} .fxw_story.fxw_image img {float: left;width: 50px;margin: 0px 0px 0px -60px;} /* Story Title */ .fxw_title {margin: 0px !important;padding: 0px !important;} .fxw_title a {text-decoration: none !important;font-weight: bold !important;font-size: 12px !important;line-height: 16px !important;color: #000099; } /* Story Description */ .fxw_desc {color: #666;padding: 0px !important;margin: 1px 0px 0px 0px !important;line-height: 14px !important;font-size: 11px !important;} /* Story Image */ img.fxw_image {width: 35px !important;height: 35px !important;margin: 2px 0px 0px -45px !important;float: left !important;} </style> <script type="text/javascript"> fxw_city = ''; fxw_limit = 6; fxw_source = ''; fxw_topic = ''; fxw_id = 'fxw_container'; fxw_target = '_blank'; fxw_showImage = false; fxw_showDescription = false; fxw_customCSS = true; </script> <script type="text/javascript" src="http://fwix.com/tools/widget/v1"></script> <a href="http://fwix.com" id="fxw_clear"><img src="http://fwix.com/images/clear.gif" border="0" title="Fwix - Your New Local Newspaper" /></a>

NEWS

WIRES

OTHER

TECHNOLOGY

NEWSPAPERS

Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference